Researchers Discover Brain Molecule, VPS35, Can Clear Alzheimer’s Tau Tangles
For the first time, researchers have determined that a molecule called VPS35 can clear tau proteins, a hallmark of Alzheimer’s disease, in the brain….
For the first time, researchers have determined that a molecule called VPS35 can clear tau proteins, a hallmark of Alzheimer’s disease, in the brain….
Among people with the Alzheimer’s gene, women are at greater risk of developing tau tangles, a hallmark of the disease, than men are. The…
University of New Mexico researchers say they’ve developed a working Alzheimer’s vaccine in mice. According to the report, published in NPJ Vaccines, the team…
New advances in brain imaging have allowed scientists from Cambridge University to track how tau, a protein that accumulates in the brain in Alzheimer’s…
Wandering, when in the context of Alzheimer’s disease, is defined as getting lost and becoming disoriented. It is a common behavior in those with…
Open your medicine cabinet, and you’ll see many examples of the most common type of medication on the market: Small molecule drugs such as…
An article published this week in the prestigious journal Nature Medicine documents what is believed to be the first evidence that Alzheimer’s disease can…
The most common form of dementia, Alzheimer’s, is a progressive, life limiting, neurodegenerative condition, which damages and destroys parts of the nervous system, especially…
From the crispy crunch of fresh veggies to the creamy indulgence of decadent desserts, we all have different food preferences. Our palates develop uniquely,…
Scientists are looking for ways to detect cognitive decline and Alzheimer’s faster, so that they could treat the disease sooner. The holy grail of…
Dementia is a term used to describe a set of symptoms: memory loss and other cognitive issues. The most common disease that causes these…
People living with Alzheimer’s disease also live with a higher risk of seizures. And that can make things complicated for doctors: Seizures are sometimes…
In the last three years, amyloid plaque-busting drugs Aduhelm (now discontinued) and Leqembi have been approved by the FDA for treating patients in the…
Scientists have developed more tools than ever to probe Alzheimer’s — from blood tests, to AI-powered cognitive assessments, and brain scans — which have…
The monoclonal antibody drugs targeting the brain’s amyloid plaques dominated the news cycle in 2023. Eisai and Biogen’s Leqembi was approved by the FDA…